Novavax
Jun 16, 2021
The COVID-19 vaccine 'Covovax' is nearing the end of its clinical testing in India, and the Serum Institute of India (SII) aims to commercialize it by September, according to its CEO, Adar Poonawalla.
Jun 15, 2021
Maryland based Novavax on Monday said that its vaccine had demonstrated 100 per cent protection in late-stage trials against SARS-CoV-2- a boost for the prospects of its Indian version, Covovax. The...
May 15, 2021
While India is battling the second wave of the Covid-19 pandemic, the scarcity of vaccines has robbed people of the hope of keeping the virus at bay.
